Cipla receives final approval for generic version of Durezol® Kumar Jeetendra | August 12, 2021 Mumbai, India; August 12, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Difluprednate Ophthalmic Emulsion 0.05% from the United States Food and Drug Administration (US FDA). Cipla’s Difluprednate Ophthalmic Emulsion 0.05% is AB-rated …
Provided more than 1 billion COVID-19 vaccine dose up until now: BioNTech Kumar Jeetendra | August 9, 2021 BioNTech and partner Pfizer have supplied more than one billion doses of their COVID-19 vaccine as per July 21, a bigger number than delivered by competitor AstraZeneca, the German biotech group said on Monday. The supply tally, up from more than 700 million doses announced by the biotech firm in June, compares with AstraZeneca saying …
Alembic Pharma gets last approval from USFDA for OCD treatment drug Kumar Jeetendra | August 5, 2021 New Delhi, Aug 5 (PTI) Drug firm Alembic Pharmaceuticals on Thursday said it has received final approval from the US health regulator for Clomipramine Hydrochloride capsules, used for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD). The company has received final approval from the US Food and Drug Administration (USFDA) for …
Consolidating AstraZeneca and mRNA COVID-19 vaccine is effective – Danish study Kumar Jeetendra | August 2, 2021 Combining AstraZeneca’s COVID-19 vaccine with a second dose from either Pfizer-BioNTech or Moderna’s jab provides “good protection”, Denmark’s State Serum Institute said on Monday. A growing number of countries are looking at switching to different COVID-19 vaccines for second doses, a measure particularly necessary in Denmark after health authorities discontinued inoculations with AstraZeneca’s vaccine in …
India says Johnson and Johnson pulls out proposal for quick COVID-19 vaccine approval Kumar Jeetendra | August 2, 2021 India’s drug regulator said on Monday that Johnson & Johnson withdrew its proposal seeking accelerated approval of its COVID-19 vaccine in the country, without giving additional details. The U.S.-based company had said in April it was seeking an approval to conduct a bridging clinical study of its Janssen COVID-19 vaccine candidate in India. Trials in the …
Pharmaceutical Roots – Almonds and Enantiomers Kumar Jeetendra | August 1, 2021 Pharmaceutical roots is a new series from LGC Mikromol, investigating and outlining the natural origins of pharmaceutical substances, and offering a deeper dive into their uses, risks, and mechanisms of action. Mandelic acid Mandelic acid is a small, aromatic compound with many different uses. Although these days it is usually prepared in the lab, mandelic …
Pharmaceutical Roots – The origins of opioids Kumar Jeetendra | August 1, 2021 Pharmaceutical roots is a new content series from LGC Mikromol, investigating and outlining the natural origins of pharmaceutical substances, and offering a deeper dive into their uses, risks, and Morphine is a type of opiate pain medication with a strong analgesic duration, lasting from three to seven hours. Named after Morpheus, the Greek god of …
Roche launches spinal muscular atrophy treatment drug in India evaluated at around Rs 6 lakh per bottle Kumar Jeetendra | July 30, 2021 Pharma major Roche on Thursday said it has launched prescription medicine Evrysdi in India, which is used for treatment of spinal muscular atrophy (SMA) in adults, children aged 2 months and older, at a maximum retail price of around Rs 6 lakh per bottle. Evrysdi was first approved by the United States Food and Drug …
Pfizer and AstraZeneca vaccine antibody levels might decrease following 2-3 months: Lancet study Kumar Jeetendra | July 27, 2021 Total antibody levels start to wane six weeks after complete immunisation with Pfizer and AstraZeneca vaccines, and can reduce by more than 50 per cent over 10 weeks, according to study published in The Lancet journal. The researchers from University College London (UCL) in the UK noted that if the antibody levels carry on dropping …
Sun Pharma, Cassiopea SpA ink permit and supply arrangements for acne treatment drug Winlevi Kumar Jeetendra | July 26, 2021 New Delhi, Jul 26 (PTI) Drug major Sun Pharma on Monday said it has signed license and supply agreements with Cassiopea SpA for acne treatment drug Winlevi in the US and Canada. Sun Pharmaceutical Industries and Cassiopea SpA on Monday announced the signing of license and supply agreements for Winlevi (clascoterone cream 1 per cent) …
BDR Pharma inks permit concurrence with DRDO to deliver COVID-19 drug 2-DG Kumar Jeetendra | July 26, 2021 BDR Pharma on Monday said it has inked a licensing pact with the Defence Research and Development Organisation (DRDO) to manufacture, distribute, and market COVID-19 drug 2-Deoxy-D-Glucose (2-DG) in the country. BDR Pharma has inked a pact with the Defence Research and Development Establishment (DRDE) and the Institute of Nuclear Medicine and Allied Sciences (INMAS) …
FDC introduced Favipiravir oral suspension to treat COVID-19 in India Kumar Jeetendra | July 12, 2021 Pharma firm FDC Ltd on Monday said it has launched oral suspension of Favipiravir to treat mild to moderate cases of COVID-19 in the country. This prescription-only Favenza oral suspension is currently available at all retail medical outlets and hospital pharmacies across India, FDC said in a statement. Convenient loading dosage of the oral suspension …
